Joaquin Duato
Joaquin Duato is the Chief Executive Officer of Johnson & Johnson, one of the world's largest pharmaceutical and medical device companies. He has been vocal about the potential impacts of US tariffs on the pharmaceutical industry, warning that such measures could lead to drug shortages and disrupt supply chains. Duato advocates for tax policy as a more effective means of boosting domestic manufacturing rather than tariffs. Under his leadership, J&J has committed to significant investments in US manufacturing.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
He introduced CEOs of major companies, including Johnson & Johnson's Joaquin Duato.
5
United States:
Johnson & Johnson, under CEO Joaquin Duato, will invest $55 billion in new manufacturing and technology upgrades.
8
Spain:
Joaquín Duato is the president and CEO of Johnson & Johnson, earning 24.3 million dollars.
7
Spain:
Joaquín Duato, president and CEO of Johnson & Johnson, earned 24.3 million dollars last year.
7
Ireland:
Joaquin Duato, who leads one of the world’s biggest pharma and medical device companies, warned that pharmaceutical tariffs could create disruptions in the supply chain.
7